Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors

Trial Profile

Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs Dendritic cells (Primary) ; Poly ICLC (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Apr 2017 Status changed from recruiting to completed.
    • 02 Dec 2015 Number of treatment arms changed from 1 to 2, A new cohort will explore the role of radiation therapy, looking for an abscopal effect as reported by ClinicalTrials.gov.
    • 26 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top